FabiFlu replaced multivitamin drug Zincovit as the top selling drug as India witnessed the highest number of Covid infections, hospitalisations and deaths in April.
Indian social media has been inundated with posts about Covid — from availability or lack of oxygen and hospital beds to treatment options. What an analysis of Google Trends found.
Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.
Modi govt's subject expert committee rejects Glenmark's proposal by highlighting that its justifications to conduct trials of favipiravir with dexamethasone were 'not adequate'.
Study will note clinical improvement of Covid patients & assess safety of favipiravir. It will also see ‘mortality, disease progression & viral clearance’ at given stages.
Glenmark conducted phase 3 clinical trials of favipiravir on 150 mild to moderate Covid patients. Adverse events, or side effects, reported in 32 patients.
Discriminatory laws limit firms from hiring willing women, and removing such barriers can help narrow the economic gap between developing and developed countries.
While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.
A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS